Tag: Immunotherapy
Immunotherapy Side Effects May Be More Common Than Thought
Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings
ACAAI: Oral Immunotherapy Is Protective in Peanut Allergy
More patients receiving AR101 able to ingest ≥600 mg peanut protein without dose-limiting symptoms
Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer
Atezolizumab plus nab-paclitaxel prolongs progression-free survival in metastatic disease
Single Agent Treats Two Cancers With Same Genetic Cause
Pembrolizumab treated colon cancer, intrahepatic cholangiocarcinoma in patient with Lynch syndrome
Novel Immunotherapy May Up Survival in Melanoma Brain Mets
Findings in patients receiving checkpoint blockade immunotherapy for melanoma brain metastases
Immunotherapy Promising for Slowing Progression of ALS
Positive results seen for autologous infusions of expanded regulatory T lymphocytes in three patients
Personalized Therapy Promising in Metastatic Breast Cancer
Adaptive transfer of mutant-protein-specific tumor-infiltrating lymphocytes leads to disease regression
Immune Checkpoint Inhibitor Efficacy Varies by Sex
Magnitude of benefit of immune checkpoint inhibitors sex-dependent for patients with advanced cancers
Uveal Effusion Reported After Initiation of Anti-PD-1, -PD-L1
Case series IDs three patients who developed uveal effusion within one to two months of initiating tx
Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
